CTLA-4 inhibitor vaccine (THERAVECTYS)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCTLA-4 inhibitor vaccine (THERAVECTYS)
Drug Alias NameCTLA-4 checkpoint inhibitor (THERAVECTYS)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheravectys Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheravectys Sa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A